NCT00370370Unknown3 期
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 试验地点
- 1
- 主要终点
- visual acuity
研究概览
简要总结
To compare the efficacy and safety results of intravitreal bevacizumab alone with bevacizumab + triamcinolone acetonide in neovascular AMD.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Cases of active neovascular AMD with visual acuity of 20/400- 20/40
排除标准
- •History of glaucoma or ocular hypertension
- •Disciform scar
研究组 & 干预措施
1
Active Comparator
Injection of intravitreal bevacizumab
干预措施: bevacizumab (Drug)
2
Active Comparator
Injection of bevacizumab + triamcinolone acetonide
干预措施: bevacizumab + triamcinolone acetonide (Drug)
结局指标
主要结局
visual acuity
次要结局
- leakage in fluorescein angiography
- intraocular pressure
- anterior chamber reaction
- central macular thickness
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
3 期
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical TrialDiabetic Macular EdemaNCT00370422Shahid Beheshti University of Medical Sciences
已完成
不适用
Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein OcclusionCentral Retinal Vein Occlusion With Macular EdemaNCT04812977Hayatabad Medical Complex30
Unknown
3 期
Effect of Intravitreal Bevacizumab on Clinically Significant Macular EdemaDiabetic Macular EdemaNCT00370669Shahid Beheshti University of Medical Sciences150
已完成
1 期
Intravitreal Bevacizumab and Low Fluence Photodynamic TherapyMyopiaNCT00802126University of Campania "Luigi Vanvitelli"16
已完成
2 期
Comparison of Intravitreal Bevacizumab and Triamcinolone with Placebo in Acute Nonarteritic Anterior Ischemic Optic NeuropathyAnterior Ischemic of Optic Nerve.Disorders of optic nerve, not elsewhere classifiedIRCT1138901221180N13Ophthalmic Research Center16